Purchases and Sales Made in Q2 2023 in An2 Therapeutics, Inc. (ANTX)
This table provides information about the institutional ownership of An2 Therapeutics, Inc. (ANTX) during Q2 2023. The information is specifically focused on institutions that hold shares of AN2 Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2023
Q2 2023
|
Tcg Crossover Management, LLC
Palo Alto, CA |
BUY
|
- |
1.29MNew |
$6.52M - $12.8M
|
1.29M
$1.93M
|
|
Aug 14, 2023
Q2 2023
|
Janus Henderson Group PLC
London, X0 |
BUY
|
- |
1MNew |
$5.06M - $9.91M
|
1M
$1.5M
|
|
Aug 14, 2023
Q2 2023
|
Octagon Capital Advisors LP
New York, NY |
BUY
|
- |
721KNew |
$3.65M - $7.14M
|
721K
$1.08M
|
|
Aug 14, 2023
Q2 2023
|
Alyeska Investment Group, L.P.
Chicago, IL |
BUY
|
- |
50K+ 103.25% |
$253K - $496K
|
98.4K
$148K
|
|
Aug 09, 2023
Q2 2023
|
Private Advisor Group, LLC
|
BUY
|
- |
45.5K+ 206.71% |
$230K - $451K
|
67.5K
$101K
|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
39.1KNew |
$198K - $388K
|
39.1K
$58.7K
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
25.1K+ 178.42% |
$127K - $248K
|
39.1K
$58.7K
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
24.2KNew |
$123K - $240K
|
24.2K
$36.4K
|
|
Aug 14, 2023
Q2 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
18.4KNew |
$92.9K - $182K
|
18.4K
$27.5K
|
|
Aug 14, 2023
Q2 2023
|
Y Intercept (Hong Kong) LTD
|
BUY
|
- |
14KNew |
$71K - $139K
|
14K
$21.1K
|
|
Aug 15, 2023
Q2 2023
|
Integrated Wealth Concepts LLC
|
BUY
|
- |
12.5KNew |
$63.2K - $124K
|
12.5K
$18.8K
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-176- 0.01% |
$891 - $1.74K
|
1.34M
$2.01M
|
|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-456- 71.03% |
$2.31K - $4.52K
|
186
$279
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-1.93K- 98.22% |
$9.77K - $19.1K
|
35
$52.5
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
SELL
|
- |
-2.55K- 4.89% |
$12.9K - $25.3K
|
49.7K
$74.5K
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-3.29K- 7.23% |
$16.6K - $32.6K
|
42.2K
$63.4K
|
|
Aug 03, 2023
Q2 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-5.7K- 17.39% |
$28.8K - $56.5K
|
27.1K
$40.6K
|
|
Aug 07, 2023
Q2 2023
|
New York State Common Retirement Fund
|
SELL
|
- |
-5.78K- 98.28% |
$29.2K - $57.3K
|
101
$152
|
|
Aug 08, 2023
Q2 2023
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-10K- 85.68% |
$50.8K - $99.4K
|
1.68K
$2.52K
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-13.7K- 52.86% |
$69.3K - $136K
|
12.2K
$18.3K
|
|
Aug 14, 2023
Q2 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-25K- 47.62% |
$126K - $248K
|
27.5K
$41.3K
|
|
Aug 14, 2023
Q2 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-49.1K- 8.16% |
$249K - $487K
|
553K
$829K
|
|
Aug 10, 2023
Q2 2023
|
Monashee Investment Management LLC
Boston, MA |
SELL
|
- |
-65.5K- 26.46% |
$331K - $649K
|
182K
$273K
|
|
Aug 14, 2023
Q2 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-66K- 9.13% |
$334K - $654K
|
657K
$986K
|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-78.8K- 81.32% |
$399K - $781K
|
18.1K
$27.2K
|
|
Aug 11, 2023
Q2 2023
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-92K- 63.46% |
$465K - $912K
|
53K
$79.4K
|
|
Aug 11, 2023
Q2 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-460K- 95.14% |
$2.33M - $4.56M
|
23.5K
$35.2K
|